Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA aminophylline/theophylline cream evaluation

This article was originally published in The Rose Sheet

Executive Summary

Could lead to warning letters or product recalls of tropical creams containing the prescription asthma medications aminophylline and theophylline if the products are found to pose health risks to consumers, FDA states. Creams formulated with aminophylline and/or theophylline are said to "smooth" hips and thighs and reduce inches from the waist and thigh areas by marketers including Smooth Contours and Mastey de Paris. FDA is analyzing several creams that contain the substances to determine the ingredients and their concentrations. FDA initiated the evaluation in response to consumer questions and recent publicity surrounding the introduction of the products, the agency says
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

RS000143

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel